<DOC>
	<DOCNO>NCT02747628</DOCNO>
	<brief_summary>Sixty female non-smoker patient , age 18-50 year ASA I II undergo elective laparoscopic cholecystectomy general anesthesia include randomize control double-blind study . Patients randomly divide 3 group 20 , C group patient receive transdermal placebo patch , TDN group ( 15 mg/16 h ) TDM group ( 7 mg/8h ) . Assessment postoperative pain , sedation , hemodynamic variable HR MAP , postoperative monitoring arterial SpO2 side effect ( e.g . nausea , vomit , pruritis , respiratory depression hemodynamic instability ) do 30 minute , 1 , 2 , 6 12 hour postoperatively . Postoperative Patient ` Surgeons ` satisfaction , Intraoperative bleed plasma cortisol ( Âµg / dl ) 2 hour postoperatively also assess .</brief_summary>
	<brief_title>Transdermal Nicotine Melatonin Patches Postoperative Pain Relief</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>60 female patient . nonsmoker patient . age 18 50 year old . ASA physical status I II . 7090 kg body weight height 160180 cm . undergoing elective laparoscopic cholecystectomy general anesthesia . Patients impaired kidney liver function . history cardiac central nervous system disease . history smoking . history drug alcohol abuse . history chronic pain daily intake analgesic . uncontrolled medical disease ( diabetes mellitus hypertension ) . history intake nonsteroidal antiinflammatory drug opioids within 24 h surgery . allergy use medication . coagulation defect . local infection site application transdermal patch . patient ` refusal . duration surgery 120 minute .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Transdermal nicotine</keyword>
	<keyword>Transdermal melatonin</keyword>
	<keyword>Postoperative pain</keyword>
	<keyword>Laparoscopic cholecystectomy</keyword>
</DOC>